Highest EBITDA
legend_toggleExplore a diverse array of industries, each represented by companies that have excelled in generating substantial EBITDA.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardEBITDA | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BCSF BCSFBain Capital Specialty Finance | $16.81 | -$0.04 | arrow_drop_down0.23% | $1.08B | 272.70K | 16.82 | $0.00 | Neutralremove | 9.93% | 11.17% | AI Analysis | |||||
AACT AACTAres Acquisition Corporation II Class A Ordinary Shares | $10.92 | $0.03 | arrow_drop_up0.27% | $682.92M | 569.61K | 10.91 | $0.00 | Neutralremove | - | 5.50% | AI Analysis | |||||
WTMA WTMAWelsbach Technology Metals Acquisition | $11.32 | $11.32 | 0.00% | $37.87M | 628.00 | 11.22 | $0.00 | Neutralremove | - | 6.33% | AI Analysis | |||||
MAIAMAIA Biotechnology | $2.19 | -$0.14 | arrow_drop_down5.95% | $52.48M | 75.60K | 2.23 | $0.00 | Neutralremove | - | 86.38% | AI Analysis | |||||
AOMRAngel Oak Mortgage | $9.37 | -$0.43 | arrow_drop_down4.39% | $220.30M | 156.97K | 9.32 | $0.00 | Neutralremove | 13.06% | -10.59% | AI Analysis | |||||
FTHY FTHYFirst Trust High Yield Opportunities 2027 Term Fund | $14.68 | $0.01 | arrow_drop_up0.06% | $539.82M | 53.35K | 14.65 | $0.00 | Neutralremove | - | 8.33% | AI Analysis | |||||
INTEWIntegral Acquisition Corporation 1 | $0.04 | $0.00 | 0.00% | $0.00 | 706.00 | 0.04 | $0.00 | Neutralremove | - | -50.50% | AI Analysis | |||||
SBTSterling Bancorp Inc-MI | $4.72 | -$0.04 | arrow_drop_down0.94% | $246.65M | 35.87K | 4.72 | $0.00 | Neutralremove | - | -19.72% | AI Analysis | |||||
RCReady Capital | $7.23 | $0.05 | arrow_drop_up0.69% | $1.21B | 1.46M | 7.20 | $0.00 | Neutralremove | 16.38% | -28.20% | AI Analysis | |||||
RWAY RWAYZRunway Growth Finance Corp. - 8.00% Notes due 2027 | $25.09 | $0.06 | arrow_drop_up0.23% | $7.30B | 53.00 | 25.09 | $0.00 | Neutralremove | - | 1.16% | AI Analysis | |||||
GPAC GPACWGlobal Partner Acquisition Corp II | $0.21 | $0.02 | arrow_drop_up10.58% | _ | 47.61K | 37.64K | $0.00 | Neutralremove | - | 1290.72% | AI Analysis | |||||
BIPH BIPHSafeplus International Holdings Limited | $18.86 | $0.04 | arrow_drop_up0.20% | $0.00 | 5.75K | 18.97 | $0.00 | Neutralremove | - | 19.14% | AI Analysis | |||||
CSLM CSLMConsilium Acquisition Corp I, Ltd. | $11.49 | $11.49 | 0.00% | $109.42M | 6.00 | 11.35 | $0.00 | Neutralremove | - | 6.17% | AI Analysis | |||||
MRKRMarker Therapeutics | $3.17 | $0.24 | arrow_drop_up8.19% | $28.46M | 12.77K | 3.10 | $0.00 | Neutralremove | - | 17.40% | AI Analysis | |||||
NEOVNeoVolta | $5.31 | $0.05 | arrow_drop_up0.95% | $177.15M | 241.94K | 5.26 | $0.00 | Neutralremove | - | 169.54% | AI Analysis | |||||
ATMV ATMVAlphaVest Acquisition | $11.24 | -$0.01 | arrow_drop_down0.08% | $78.82M | 1.00 | 11.24 | $0.00 | Sellkeyboard_arrow_down | - | 5.63% | AI Analysis | |||||
BANXArrowmark Financial | $20.43 | $0.19 | arrow_drop_up0.93% | $145.18M | 13.47K | 20.36 | $0.00 | Neutralremove | 8.82% | 17.17% | AI Analysis | |||||
ZIVO ZIVOWZIVO Bioscience | $0.35 | $0.13 | arrow_drop_up65.87% | $0.00 | 905.00 | 2.46K | $0.00 | Neutralremove | - | - | AI Analysis | |||||
NXG NXGNXG NextGen Infrastructure Income Fund | $47.45 | $0.42 | arrow_drop_up0.89% | $126.18M | 24.30K | 47.21 | $0.00 | Neutralremove | - | 51.93% | AI Analysis | |||||
SSIC SSICSilver Spike Investment Corp. Common Stock | $11.90 | $0.15 | arrow_drop_up1.27% | $66.71M | 77.81K | 20.11K | $0.00 | Neutralremove | 9.05% | 24.80% | AI Analysis |
Showing 3401-3420 of 4977
Results per page:
About Highest EBITDA
Discover the stocks with the highest EBITDA, a significant financial metric indicating a company's operational profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, reflects a firm's ability to generate profits from its core operations without factoring in financing and accounting decisions.
Investors seek companies with robust EBITDA figures as it showcases their potential for sustainable growth and cash flow generation. High EBITDA stocks often demonstrate strong financial health and efficiency, making them attractive choices for long-term investment strategies.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools